Abstract: A networked data processing system that provides an application programming interface (API) for consumer-permissioned data, such as academic data, employment data and income data. In some implementations, the data processing system enables application developers to integrate consumer-permissioned data (such as academic data) into their applications. In some implementations, the API enables a developer to focus on other aspects of a given application, while leveraging the data processing system to handle aspects of gathering and processing the source data, such as authenticating the provenance of the source data, handling user permissions, extracting the source data, reviewing the source data, verifying the source data, generating one or more scores from the source data, analyzing the source data relative to a defined purpose, providing the information sought from the analyzed data, and the like.

Abstract: A networked data processing system that provides an application programming interface (API) for consumer-permissioned data, such as academic data, employment data and income data. In some implementations, the data processing system enables application developers to integrate consumer-permissioned data (such as academic data) into their applications. In some implementations, the API enables a developer to focus on other aspects of a given application, while leveraging the data processing system to handle aspects of gathering and processing the source data, such as authenticating the provenance of the source data, handling user permissions, extracting the source data, reviewing the source data, verifying the source data, generating one or more scores from the source data, analyzing the source data relative to a defined purpose, providing the information sought from the analyzed data, and the like.

Abstract: A carbon-based additive for negative active materials includes carbon nanostructures free of a fiber substrate, carbon nanostructures fused to a fiber substrate or any combination thereof. In many cases, the carbon-based additive further includes carbon black. The additive is used to prepare electrode compositions for lead acid batteries. Batteries that include such electrode compositions are characterized by improved dynamic charge acceptance and lead utilization, typically at acceptable water loss levels. Some of the batteries described herein exhibit a negligible memory effect.

Abstract: A method of treating hypoxic ischemic encephalopathy (HIE) is described in which a classical complement pathway inhibitor is administered to a neonate. The classical pathway inhibitor can be PIC1, and may have one or more PEG moieties. Treatment of the neonate with the classical complement pathway inhibitor can inhibit inflammation and oxidative damage, such as might arise from ischemia-reperfusion injury. Improvement in fine motor performance, spatial memory and may be achieved. The method may be effective to treat or prevent cerebral palsy.

Abstract: Carbon nanostructures are used to prepare electrode compositions for lithium ion batteries. In one example, a cathode for NCM batteries includes three-dimensional carbon nanostructures which are made of highly entangled nanotubes, fragments of carbon nanostructures and/or fractured nanotubes which are derived from the carbon nanostructures, are branched and share walls with one another. Amounts of carbon nanostructures employed can be less than or equal to 1 weight % relative to the electrode composition.

Abstract: A photo-curable composition for use in additive manufacturing, said composition comprising: a) at least one photocurable monomer or oligomer; b) a photoinitiator for polymerization of the monomer; and, from 0.01 to 1 wt. %, based on the weight of the composition, of c) CNS-derived materials. Following polymerization, the resulting polymerized composition has a volume resistivity no greater than 105 ohm·cm.

Abstract: Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to the patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/?L.

Abstract: Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to the patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/?L.

Abstract: Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to a patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/?L.

Abstract: A compression therapy device for vascular diseases and other therapies including a bladder a lever arm acting on the outer surface of the bladder such that cyclical operation of an actuator on the lever arm creates cyclical changes in pneumatic pressure in the therapeutic portion of the bladder.

Abstract: A GPU of a processor performers load balancing by enabling and disabling CUs based on the GPU's processing load. A power control module identifies a current processing load of the GPU based on, for example, an activity level of one or more modules of the GPU. The power control module also identifies an expected future processing load of the GPU based on, for example, a number of threads (wavefronts) scheduled to be executed at the GPU. Based on a combination of the current processing load and the expected future processing load, the power control module sets the number of CUs of the GPU that are enabled and the number that are disabled (e.g. clock gated or power gated). By changing the number of enabled CUs based on processing load, the power control module maintains performance at the GPU while conserving power.

Abstract: Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising: 1) identifying a patient having moderate to severe eosinophilic asthma, wherein the patient's symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/?L; and 2) administering to said patient a therapeutically effective dose of reslizumab.

Abstract: A compression therapy device for vascular diseases and other therapies comprising a bladder a lever arm acting on the outer surface of the bladder such that cyclical operation of an actuator on the lever arm creates cyclical changes in pneumatic pressure in the therapeutic portion of the bladder.

Abstract: Patient support systems are generally disclosed. An example patient support system may be configured to provide a predictive bed-exit alarm and/or a patient weight. An example embodiment may include a support structure including independently inflatable supports, an inflatable mat beneath the inflatable supports, and pressure detectors associated with the inflatable supports and the inflatable mat. An alarm logic may be configured to initiate a predictive bed-exit alarm sequence upon determining that at least one of the pressures of the inflatable supports is at about its respective unloaded pressure. A patient weight logic may be configured to output a patient weight based at least partially upon a difference between an unloaded pressure and a loaded pressure of the inflatable mat.

Abstract: Patient support systems are generally disclosed. An example patient support system may be configured to provide a predictive bed-exit alarm and/or a patient weight. An example embodiment may include a support structure including independently inflatable supports, an inflatable mat beneath the inflatable supports, and pressure detectors associated with the inflatable supports and the inflatable mat. An alarm logic may be configured to initiate a predictive bed-exit alarm sequence upon determining that at least one of the pressures of the inflatable supports is at about its respective unloaded pressure. A patient weight logic may be configured to output a patient weight based at least partially upon a difference between an unloaded pressure and a loaded pressure of the inflatable mat.

Abstract: Patient support systems are generally disclosed. An example patient support system may include a base; first and second longitudinally oriented sidewalls extending upward from lateral side portions of the base; a substantially vapor-impermeable barrier on the top surface of the base and on inwardly facing surfaces of the sidewalls; a substantially vapor-permeable top cover extending between the sidewalls such that a generally longitudinally oriented channel configured to receive airflow therethrough is substantially defined by a lower surface of the top cover, an upper surface of the barrier on the base, and inwardly facing surfaces of the barrier on the sidewalls; a supply conduit extending from an exterior air supply connector to an internal air supply opening within the channel; an air discharge opening within the channel; and an inflatable support disposed in the channel. The interior volume of the inflatable support may be fluidicly isolated from the channel.

Abstract: This invention is directed to a process for making a thermally inhibited polysaccharide by dehydrating a polysaccharide to substantially anhydrous or anhydrous conditions and thermally inhibiting the substantially anhydrous or anhydrous polysaccharide at a temperature of 100° C. or greater for a time sufficient to inhibit the polysaccharide in an oxygen enriched concentration of at least 6.5 moles/m3.

Abstract: A method for managing work distribution in a processor including a plurality of instruction data modules, is provided. The method includes analyzing work units received by the processor and comparing the utilization level in each active module within the plurality with a first predetermined threshold. The work units are distributed across selected ones of the modules within the plurality based upon the analyzing and the comparing.

Abstract: The present invention relates to starch-hydrocolloid complexes, their preparation and their use in foods. The complexes positively impact the foods into which they are incorporated to give longer-lasting and/or more potent satiety, thereby helping energy management. The invention further relates to the reduction of food intake and/or management of weight by increasing such satiety.

Abstract: Embodiments of the invention are directed to systems, methods and computer program products for implementing rule-based offer association, queuing input information for performing rule-based offer association, and implementing an intelligent offer tool for determining whether to present an offer to a user. The invention enables an entity to send targeted offers to a user that enables the user to receive at least one of a discount or a rebate on a purchase from a merchant.